Skip to main content
Clinical Trials/NCT00582335
NCT00582335
Completed
Not Applicable

Identification of New Colorectal Cancer Genes

Memorial Sloan Kettering Cancer Center1 site in 1 country337 target enrollmentFebruary 10, 1998

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
337
Locations
1
Primary Endpoint
Evidence of mutations in selected candidate genes
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to define new genes for family risks of developing colon cancer.

Detailed Description

Colorectal cancer is one of the most significant causes of cancer morbidity and mortality in the United States. In 1997, approximately 130,000 men and woman were diagnosed with colorectal cancer (fourth most common cancer site) and approximately 55,000 died of this disease (second most common cause of cancer deaths); (Cancer Facts \& Figures, 1997). Genetic factors clearly contribute to the etiology of colorectal cancer. Because there is evidence to suggest genetically determined susceptibility to colorectal cancer exists in a proportion of newly diagnosed cases each year, we are conducting a study to identify new genes that are associated with an increased susceptibility to familial colorectal cancer by analysis of families with a clustering of colorectal cancers.

Registry
clinicaltrials.gov
Start Date
February 10, 1998
End Date
December 17, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or greater
  • Able to provide informed consent
  • Any family in which a minimum of two first-degree relatives either are, or have previously been, affected with primary colorectalcancer. These "minimum inclusion criteria" must be met within three generations of the proband or kindreds in which colorectal cancer and lymphoma or renal cell cancer are present or in kindreds in which lymphoma alone or lymphoma and renal cell cancer are present

Exclusion Criteria

  • Age less than 18 years
  • Family not at increased risk for familial colorectal cancer (see Section 4.1)
  • Family with a hereditary polyposis syndrome (e.g. classic FAP)
  • Not able to provide informed consent

Outcomes

Primary Outcomes

Evidence of mutations in selected candidate genes

Time Frame: 10 years 10 months

Study Sites (1)

Loading locations...

Similar Trials